Executive leadership at MILESTONE SCIENTIFIC.
Board of directors at MILESTONE SCIENTIFIC.
Research analysts who have asked questions during MILESTONE SCIENTIFIC earnings calls.
AV
Anthony Vendetti
Maxim Group
2 questions for MLSS
Also covers: AEMD, AGFY, BHST +19 more
Bruce Jackson
The Benchmark Company LLC
1 question for MLSS
Also covers: BFRI, BLTE, BSEM +8 more
NS
Nicholas Sherwood
Maxim Group
1 question for MLSS
Also covers: BRFH, CUTR, HSDT +3 more
RD
Richard Dorado
DDF
1 question for MLSS
Recent press releases and 8-K filings for MLSS.
Milestone Scientific provides business update under new CEO
MLSS
CEO Change
New Projects/Investments
Revenue Acceleration/Inflection
- Milestone Scientific Inc. (MLSS) provided a business update on October 14, 2025, detailing transformation and growth initiatives under its new Chief Executive Officer, Eric Hines, who joined two months prior.
- Under Mr. Hines' leadership, the company has implemented strategic actions including expanding North American sales and digital marketing in the dental segment, planning a guided relaunch of CompuFlo® in the medical segment, and reducing operating expenses across the organization.
- During the third quarter, Milestone Scientific reduced operating expenses by approximately 20% compared to the same period in 2024, while achieving modest revenue growth and an uptick in recurring revenue from CompuFlo® disposables.
Oct 14, 2025, 11:50 AM
Milestone Scientific Notifies of NYSE American Listing Non-Compliance
MLSS
Delisting/Listing Issues
- Milestone Scientific Inc. (MLSS) received a letter from NYSE American LLC on October 8, 2025, stating it is not in compliance with continued listing standards Sections 1003(a)(ii) and 1003(a)(iii).
- The non-compliance stems from having stockholders' equity of approximately $3.3 million as of June 30, 2025, and experiencing losses in each of its five most recent fiscal years ended December 31, 2024. This falls below the required $4 million (for losses in three of four years) and $6 million (for losses in five years) stockholders' equity thresholds.
- The company is required to submit a plan of compliance by November 7, 2025, detailing actions to regain compliance by April 8, 2027.
- Milestone Scientific's common stock will continue to trade on the NYSE American under "MLSS" while it works to regain compliance, and the notification does not immediately affect its business operations or SEC reporting obligations.
Oct 14, 2025, 11:45 AM
Quarterly earnings call transcripts for MILESTONE SCIENTIFIC.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more